Department of Cardiology, University of Copenhagen, Denmark.
Isala Heart Centre, The Netherlands.
Eur J Prev Cardiol. 2016 Oct;23(2 suppl):27-40. doi: 10.1177/2047487316670063.
Cardiac rehabilitation (CR) is an evidence-based intervention to increase survival and quality of life. Yet studies consistently show that elderly patients are less frequently referred to CR, show less uptake and more often drop out of CR programmes.
The European study on effectiveness and sustainability of current cardiac rehabilitation programmes in the elderly (EU-CaRE) project consists of an observational study and an open prospective, investigator-initiated multicentre randomised controlled trial (RCT) involving mobile telemonitoring guided CR (mCR).
The aim of EU-CaRE is to map the efficiency of current CR of the elderly in Europe, and to investigate whether mCR is an effective alternative in terms of efficacy, adherence and sustainability.
The EU-CaRE study includes patients aged 65 years or older with ischaemic heart disease or who have undergone heart valve surgery. A total of 1760 patients participating in existing CR programmes in eight regions of Europe will be included. Of patients declining regular CR, 238 will be included in the RCT and randomised in two study arms. The experimental group (mCR) will receive a personalised home-based programme while the control group will receive no advice or coaching throughout the study period. Outcomes will be assessed after the end of CR and at 12 months follow-up. The primary outcome is VO and secondary outcomes include variables describing CR uptake, adherence, efficacy and sustainability.
The study will provide important information to improve CR in the elderly. The EU-CaRE RCT is the first European multicentre study of mCR as an alternative for elderly patients not attending usual CR.
心脏康复(CR)是一种基于证据的干预措施,可以提高生存率和生活质量。然而,研究一致表明,老年患者接受 CR 的频率较低,接受程度较低,退出 CR 项目的频率较高。
欧洲老年当前心脏康复计划的有效性和可持续性研究(EU-CaRE)项目包括一项观察性研究和一项开放前瞻性、研究者发起的多中心随机对照试验(RCT),涉及移动远程监测指导的 CR(mCR)。
EU-CaRE 的目的是绘制欧洲老年 CR 的效率图,并研究 mCR 在疗效、依从性和可持续性方面是否是一种有效的替代方法。
EU-CaRE 研究包括年龄在 65 岁或以上的缺血性心脏病患者或接受过心脏瓣膜手术的患者。将纳入欧洲 8 个地区的 1760 名现有 CR 项目的患者。对于拒绝常规 CR 的患者,238 名将纳入 RCT 并随机分为两个研究组。实验组(mCR)将接受个性化的家庭计划,而对照组在整个研究期间将不接受任何建议或辅导。将在 CR 结束后和 12 个月随访时评估结果。主要结果是 VO,次要结果包括描述 CR 接受程度、依从性、疗效和可持续性的变量。
该研究将提供重要信息,以改善老年患者的 CR。EU-CaRE RCT 是欧洲首个关于 mCR 作为不参加常规 CR 的老年患者替代方案的多中心研究。